- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02879201
Continuous Venovenous Hemodiafiltration Versus Sustained Low-efficiency Hemodialysis for Critically Ill Patients With Acute Kidney Injury in Intensive Care Unit
August 31, 2023 updated by: Thananda Trakarnvanich, Bangkok Metropolitan Administration Medical College and Vajira Hospital
The investigators conducted a comparison trial between SLED and CRRT in critically ill patients to evaluate the outcome for all cause mortality at 30 day .
The secondary outcome were recovery of renal function, complications during therapy and duration of hospitalization.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators performed a single center experience accumulated over 12 months since February 2009 with a continuous venovenous hemodiafiltration (CVVHDF) and hybrid technique named sustained low-efficiency dialysis (SLED).
The primary end point was death from any cause by day 30.
Intensive care unit (ICU) patients were eligible for inclusion when serum creatinine was > 2 mg/dL, and renal replacement therapy (RRT) was initiated.
The selected patients were treated with CVVHDF or SLED.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10300
- Renal Unit, BMA Medical College and Vajira Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The inclusion criteria were
- AKI requiring RRT
- Hemodynamic instability defined by systolic blood pressure ≤ 90 mmHg and/or diastolic blood pressure ≤ 60 mmHg
- Patients requiring initiation to vasopressor support
Exclusion Criteria:
- Patients with pre-existing chronic kidney disease ( eGFR less than 30 mLmin/1.73m2) were excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Slow efficiency dialysis
SLED is a kind of hemodialysis technique performed using Fresenius 4008B dialysis machine with FDX 120 GW (NIKKISO Japan) dialyzer.
SLED sessions were 6-8 hour duration, three times per week (except Sunday), In case of severe volume overload, the session could be increased to meet clinical situation.
Blood flow was maintained between 150-200 mL/hr and the dialysate flow of 300 mL/hr.
Both the groups use unfractionated heparin as anticoagulant to prevent clotting of the extracorporeal circuit .the
target partial thromboplastin time( PTT) was not more than twice the control level.
|
Slow dialysis 4 times weekly 8 hours CVVHDF predilution mode
Other Names:
|
No Intervention: Continuous renal replacement therapy
CRRT is a kind of therapy involved continuos dialysis throughout 24 hours by using Edward Delivery system (Edward Life Science) as continuous venovenous hemodiafiltration (CVVHDF) mode using Aquamax HF 12 dialyzer.
Blood flow rate was kept from 100-200 mL/hr and target effluent rates of 20 mL/hr .
The substitution fluid was infused at a rate of 1,000 ml/hr with ultrafiltration rate at 100-300 mL/hr.Intervention here is the different mode of dialysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause mortality
Time Frame: 30 day
|
ll-cause mortality at 30 days following RRT initiation
|
30 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numbers of patients with abnormal laboratory values
Time Frame: 30 days
|
Renal function impairment
|
30 days
|
ICU stay
Time Frame: 30 days
|
Total days in ICU
|
30 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events during treatment
Time Frame: 30 days
|
Number of patients with catheter infection
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
July 25, 2016
First Submitted That Met QC Criteria
August 22, 2016
First Posted (Estimated)
August 25, 2016
Study Record Updates
Last Update Posted (Actual)
September 1, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 036/59
- Vajira002 (Registry Identifier: SLED)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Kidney Injury
-
Instituto Nacional de Cardiologia Ignacio ChavezInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranUnknownKidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal InjuriesMexico
-
Yonsei UniversityCompletedAcute Kidney Injury(Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery)Korea, Republic of
-
University Hospital, GhentWithdrawn
-
Beni-Suef UniversityCairo UniversityRecruitingAKI - Acute Kidney InjuryEgypt
-
University Hospital MuensterBaxter Healthcare CorporationCompletedAcute Kidney Injury (AKI)Spain, France, United States, Turkey, Germany, Egypt, Italy, Libyan Arab Jamahiriya, Malta, North Macedonia, Palestinian Territory, occupied, Russian Federation, Saudi Arabia, Slovenia
-
Chinese PLA General HospitalBeijing Tsinghua Changgeng HospitalCompletedPostoperative Acute Kidney InjuryChina
-
Chinese PLA General HospitalCompletedPostoperative Acute Kidney InjuryChina
-
Astellas Pharma IncCompleted
-
South Egypt Cancer InstituteCompletedAcute Kidney Injury (AKI)Egypt
-
Xuzhou Medical UniversityUnknownPostoperative Acute Kidney Injury
Clinical Trials on Slow efficiency dialysis
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Heidelberg UniversityCompletedAcute Renal Failure | DialysisGermany
-
Groupe Hospitalier Sud Ile-de-FranceRecruitingAcute Kidney InjuryFrance
-
MexbrainNot yet recruitingMultiple Organ Failure | Acute on Chronic Liver FailureFrance
-
Centre Hospitalier Sud FrancilienAvailable
-
Bahçeşehir UniversityOndokuz Mayıs UniversityCompleted
-
CHU de ReimsRecruitingChronic Kidney InsufficienciesFrance
-
University Hospital, MontpellierRecruitingChronic Kidney DiseasesFrance
-
Dr. Tarit SahaCompleted
-
Michigan State UniversityUniversity of MichiganCompletedCardiovascular Diseases in Old Age